Viewpoint Molecular Targeting, Inc. Email Format

Pharmaceutical ManufacturingIowa, United States2-10 Employees

Viewpoint Molecular Targeting, Inc. is a radiopharmaceutical company focused on developing alpha-particle based cancer therapies and complementary diagnostic imaging agents. Its alpha radiotherapies are designed to deliver targeted radiation to cancer cells through specialized targeting peptides. The diagnostic components reuse the same targeting peptides to visualize tumors and support personalized treatment planning, and the company is based in Coralville, Iowa.

Its melanoma program (VMT01) and neuroendocrine tumor program (VMT-α-NET) are entering Phase 1 imaging studies and are planned to advance to Phase 1/2a therapy trials at two leading academic institutions. In February 2023, Viewpoint Molecular Targeting merged with Isoray, Inc., forming a combined entity.

Sign up for free to view info

Company overview Employee directory